Mucosal tumor necrosis factor-α production and extensive disruption of sulfated glycosaminoglycans begin within hours of birth in neonatal respiratory distress syndrome

Pediatric Research

Volumn 40, Issue 3, 1996, Pages 484-489

  Murch, Simon H ^a,b,f   Costeloe, Kate ^a   Klein, Nigel J ^c   Rees, Helene ^b   McIntosh, Neil ^d   Keeling, Jean W ^e   MacDonald, Thomas T ^b  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; GLYCOSAMINOGLYCAN POLYSULFATE; HYALIN; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; MONOCYTE; NEUTROPHIL; NEWBORN; NEWBORN MORTALITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0029812052     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199609000-00019     Document Type: Article

References (45)

1. Avery ME, Fletcher BD, Williams RG 1981 Hyaline membrane disease. In: The Lung and Its Disorders in the Newborn Infant. WB Saunders, Philadelphia, pp 228-237
2. Avery ME, Mead J 1959 Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97:517-523
3. Robertson B 1989 The evolution of neonatal respiratory distress syndrome into chronic lung disease. Eur Resp 2(suppl):33s-37s
4. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer P, Edwards DK 1983 Elastase and al-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 72:656-666
5. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD 1984 Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130:817-821
6. Murch SH, MacDonald TT, Wood CBS, Costeloe KL 1992 Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 47:44-47
7. Murch SH, Costeloe K, Klein NJ, MacDonald TT Early production of macrophage inflammatory protein-1α occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 40:490-497
8. Groneck P, Reuss D, Gotze-Speer B, Speer CP 1993 Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 122:938-944
9. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ 1995 Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child 72:F90-F96
10. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP 1994 Association of pulmonary inflammation and increased microvascular permeability during the development of broncho-pulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm infants. Pediatrics 93:712-718
11. Arnon S, Grigg J, Silverman M 1993 Pulmonary inflammatory cells in ventilated preterm infants: effects of surfactant treatment. Arch Dis Child 69:44-48
12. Kovacs EJ 1991 Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 12:17-23
13. Kovacs EJ, DiPietro LA 1994 Fibrogenic cytokines and connective tissue production. FASEB J 8:854-861
14. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P 1989 Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170:655-663
15. Piguet PF, Vesin C, Grau GE, Thompson RC 1993 Interleukin-1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5:57-61
16. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA 1995 Role of macrophage inflammatory protein-1α (MIP-1α) in acute lung injury in rats. J Immunol 154:4793-4802
17. Klein NJ, Shennan GI, Heyderman RS, Levin M 1992 Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci 102:821-832
18. Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein NJ 1993 Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 341:711-714
19. Comper WD, Laurent TC 1978 Physiological function of connective tissue polysaccharides. Physiol Rev 58:255-315
20. Powers MR, Blumenstock FA, Cooper JA, Malik AB 1989 Role of albumin arginyl sites in albumin-induced reduction of endothelial hydraulic conductivity. J Cell Physiol 141:558-564
21. Sunergren KP, Fairman RP, deBlois GG, Glauser FL 1987 Effects of protamine, heparinase and hyaluronidase on endothelial permeability and surface charge. J Appl Physiol 63:1987-1992
22. Kjellen L, Lindahl U 1991 Proteoglycans: structures and interactions. Annu Rev Biochem 60:443-475
23. Danon D, Skutelsky E 1976 Endothelial surface charge and its possible relationship to thrombogenesis. Ann NY Acad Sci 275:47-63
24. Comper WD, Zamparo O 1990 Hydrodynamic properties of connective tissue polysaccharides. Biochem J 269:561-564
25. Mast BA, Haynes JH, Krummel TF, Diegalmann RF, Cohen IK 1992 In vivo degradation of fetal wound hyaluronic acid results in increased fibroplasia, collagen deposition and neovascularization. Plast Reconstr Surg 89:503-509
26. Murch SH 1995 Sulphation of proteoglycans and intestinal function. J Gastroenterol Hepatol 10:210-212
27. Bouziges F, Simon-Assmann P, Simo P, Kedinger M 1991 Changes in glycosaminoglycan expression in the rat developing intestine. Cell Biol Int Rep 15:97-106
28. Murch SH, Winyard PJD, Koletzko S, Wehner B, Cheema HA, Risdon RA, Phillips AD, Meadows N, Klein NJ, Walker-Smith JA 1996 Congenital enterocyte heparan sulphate deficiency is associated with massive albumin loss, secretory diarrhoea and malnutrition. Lancet 347:1299-1301
29. Lennox B 1975 Observations on the accuracy of point counting including the description of a new graticule. J Clin Pathol 28:99-103
30. Matzner Y, Bar-Ner M, Yahalom J, Ishai-Michaeli R, Fuks Z, Vlodavsky I 1985 Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. J Clin Invest 76:1306-1313
31. Woessner JF 1991 Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 5:2145-2154
32. Lionetti P, Breese E, Braegger CP, Murch SH, Taylor J, MacDonald TT 1993 T cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology 105:373-381
33. Pender SLF, Lionetti P, Murch SH, Wathen N, MacDonald TT 1996 Proteolytic degradation of intestinal mucosal extracellular matrix following lamina propria T cell activation. Gut (in press)
34. Gijbels K, Galardy RE, Steinman 1994 Reversal of experimental autoimmune encephalomyelitis with a hydroxyamate inhibitor of matrix metalloproteases. J Clin Invest 94:2177-2182
35. Sundell HW, Grogaard J, Rojas J, Gray ME, Mohan P, Brigham KL 1989 Lung vascular permeability changes in lambs with hyaline membrane disease. J Dev Physiol 12:353-362
36. Jobe A 1989 Protein leaks and surfactant dysfunction in the pathogenesis of respiratory distress syndrome. Eur Respir J 2(suppl):27S-32S
37. Watts CL, Fanaroff AA, Bruce MC 1992 Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr 120:614-620
38. Watts CL, Bruce MC 1992 Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia. J Pediatr 121:597-607
39. Sampson PM, Rochester CL, Freundlich B, Elias JA 1992 Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest 90:1492-1503
40. Juul SE, Kinsella M, Wight TN, Hodson WA 1993 Alterations in nonhuman primate (M. nemestrina) lung proteoglycans during normal development and acute hyaline membrane disease. Am J Respir Cell Mol Biol 8:229-310
41. Bishop JE, Mitchell JJ, Absher PM, Baldor L, Geller HA, Woodcock-Mitchell J, Hamblin MJ, Vacek P, Low RB 1993 Cyclic mechanical deformation stimulates lung fibroblast proliferation and autocrine growth factor activity. Am J Respir Cell Mol Biol 9:126-133
42. de la Monte SM, Hutchins GM, Moore GW 1986 Respiratory epithelial cell necrosis is the earliest lesion of hyaline membrane disease of the newborn. Am J Pathol 123:155-160
43. Carone FA, Spector WG 1960 The interaction of plasma proteins and mucoid substances in the pathogenesis of pulmonary hyaline membranes. J Pathol Bacteriol 80:63-71
44. Margraf LR, Paciga JE, Balis JU 1990 Surfactant-associated glycoproteins accumulate in alveolar cells and secretions during reparative stage of hyaline membrane disease. Hum Pathol 21:392-396
45. Springer TA 1994 Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314